What is your approach to choosing a conditioning regimen for allogeneic transplant in AML?

Randomized trials in AML and to a lesser degree in MDS have shown that dose intensity is important for long term disease control. Following the guiding principle of trying to optimize the conditioning for each individual patient I use the following guidelines

1 patients less than 60 with HCTCI 3 or...